The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, ...

Heat stroke poses a significant health risk, especially during extreme temperature conditions. As global temperatures rise ...

UTA study finds that Americans over 65 who experienced parental divorce as children are more likely to suffer a stroke ...

For patients with acute ischemic stroke (AIS) whose symptoms began 4.5 to 24 hours earlier, alteplase is associated w ...

Transplantation of neural stem cells improved neurologic and motor function for adults with chronic ischemic stroke at 12 ...

A new study reveals that switching to potassium-enriched salt substitutes can reduce stroke recurrence and mortality, offering hope for millions.

Use of DOACs in patients with ICH and AF resulted in a remarkable reduction in ischemic stroke, but that benefit was partially offset by an increase in ICH recurrence.

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

The findings are disappointing, but questions around intervention timing, patient population, and others remain to be ...

In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those who ...

Outside of stroke, tDCS has had major setbacks in recent years. The DepressionDC study found it to be no better than sham as ...